Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Enterprise Value (2016 - 2025)

CorMedix's Enterprise Value history spans 13 years, with the latest figure at -$148.5 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 187.36% year-over-year to -$148.5 million; the TTM value through Dec 2025 reached -$148.5 million, down 187.36%, while the annual FY2025 figure was -$148.5 million, 187.36% down from the prior year.
  • Enterprise Value for Q4 2025 was -$148.5 million at CorMedix, down from -$55.7 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$19.8 million in Q2 2023 and bottomed at -$190.7 million in Q2 2025.
  • The 5-year median for Enterprise Value is -$51.7 million (2024), against an average of -$63.8 million.
  • The largest annual shift saw Enterprise Value tumbled 564.01% in 2021 before it surged 48.39% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$65.5 million in 2021, then skyrocketed by 33.9% to -$43.3 million in 2022, then dropped by 23.21% to -$53.3 million in 2023, then rose by 3.05% to -$51.7 million in 2024, then crashed by 187.36% to -$148.5 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Enterprise Value are -$148.5 million (Q4 2025), -$55.7 million (Q3 2025), and -$190.7 million (Q2 2025).